Access to Care for Multiple Sclerosis in Times of Economic Crisis in Greece – the HOPE II Study

Access to Care for Multiple Sclerosis in Times of Economic Crisis in Greece – the HOPE II Study

Background While there is currently no cure for multiple sclerosis (MS), treatment with biologic diseasemodifying drugs (bDMDs) can reduce the impact of the condition on the lives of patients. In Greece, the regulatory change in the distribution system of bDMDs, limited their administration throug...

Full description

Bibliographic Details
Main Authors: Kyriakos Souliotis, Elena Alexopoulou, Manto Papageorgiou, Anastasia Politi, Panagiota Litsa, Xenophon Contiades
Format: Article
Language:English
Published: Kerman University of Medical Sciences 2016-02-01
Series:International Journal of Health Policy and Management
Subjects:
Multiple Sclerosis (MS)
Patient Access
Biologics
Pharmaceutical Policy
Recession
Greece
Online Access:http://www.ijhpm.com/pdf_3100_4e429ed61f7b5cd9ba6aee079bb957e0.html

Similar Items

Similar Items